Parcion Private Wealth LLC

Position in EXEL — Exelixis, Inc.

CIK 1801263 BELLEVUE, WA

Position in EXEL

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$483,842

-$73,500 QoQ

Shares Held

11,281

-11.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Parcion Private Wealth LLC holds $2,366,921 across 5 Biotechnology names. EXEL ranks #3 (20.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,194	$922,532
2	INCY	Incyte Corp	5,586	$525,754
3	EXEL	Exelixis, Inc. This page	11,281	$483,842
4	BMRN	Biomarin Pharmaceutical Inc	7,347	$415,032
5	FATE	Fate Therapeutics Inc	16,468	$19,761

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$483,842	11,281	-11.3%	Shares	Sole	2026-04-22
2025-12-31	$557,342	12,716	+80.2%	Shares	Sole	2026-01-26
2025-09-30	$291,495	7,058	+23.2%	Shares	Sole	2025-10-14
2025-06-30	$252,622	5,731	-42.7%	Shares	Sole	2025-07-30
2020-03-31	$172,303	10,006	—	Shares	Sole	2020-04-29
No filing history on record for this holder in this stock.